+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran



Biliary excretion of mitomycin C dextran conjugates in relation to physicochemical characteristics of carrier dextran



Journal of Pharmacobio-Dynamics 13(7): 441-447



Biliary excretion characteristics of polymeric prodrugs of mitomycin C (MMC), mitomycin C-dextran conjugates with cationic or anionic charge (MMC-Dcat, MMC-Dan) and with different molecular weights of dextran (10,000, 70,000, and 500,000) were studied in rat. Following intravenous injection, bile was periodically collected and concentrations of free and dextran-conjugated MMC in it were determined by bioassay. MMC administered as a free form was excreted rapidly into bile and 1.8% of the dose was recovered within 2 h. A small amount of MMC was gradually excreted into bile after administration of all MMC-Ds and total recovery at 8 h was less than 1% of dose. In this case, a major part of excreted MMC was recovered as a conjugated form. MMC-Dcat gave a larger total excretion of MMC than MMC-Dan and excretion was also affected by the molecular weight of carrier dextran. The biliary recovery of MMC-Dcat labeled with 14C at a spacer moiety was significantly higher than that of conjugated MMC determined by bioassay suggesting release and/or inactivation of MMC in MMC-D during the circulation in the body. These results were compared with biliary excretion of model macromolecules with the same molecular weight but different electric charge in order to clarify the effect of electric charge on the biliary excretion of macromolecules. Cationic macromolecules exhibited higher biliary excretion in relation to greater hepatic uptake.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007055669

Download citation: RISBibTeXText

PMID: 1705289

DOI: 10.1248/bpb1978.13.441


Related references

Urinary excretion characteristics of a polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate. Journal of Pharmacobio-Dynamics 8(5): 357-364, 1985

Development of a novel polymeric prodrug of mitomycin c mitomycin c dextran conjugate with anionic charge i. physicochemical characteristics and in vivo and in vitro antitumor activities. International Journal of Pharmaceutics 37(1-2): 135-144, 1987

Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. I. Physicochemical characteristics and in vivo and in vitro antitumor activities. International Journal of Pharmaceutics 37(1): 135-143, 1987

Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection. Journal Of Controlled Release. 52(3): 239-252, Ch 31, 1998

Changes in blood dextran level and urinary dextran excretion in rabbits after infusion of dextran preparations of various molecular weights. Lissak, Ked By . Thirty-Fourth Annual Conference Of The Hungarian Physiological Society. Debrecen, 4-6 July . Abstracts. 223p. Akademiai Kiado: Budapest, Hungary. 82, 1971

Regeneration characteristics of mitomycin C-dextran conjugate in relation to its activity. Chemical and Pharmaceutical Bulletin 31(6): 2055-2063, 1983

Prevention of dextran-induced anaphylactic reactions by hapten inhibition. II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40. Acta Chirurgica Scandinavica 149(4): 349-353, 1983

Prevention of dextran-induced anaphylactic reactions by hapten inhibition. I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15% administered before dextran 70 or dextran 40. Acta Chirurgica Scandinavica 149(4): 341-348, 1983

Prevention of dextran-induced anaphylactic reactions by hapten inhibition. III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40. Acta Chirurgica Scandinavica 149(4): 355-360, 1983

Disposition and tumor localization of mitomycin C-dextran conjugates in mice. Pharmaceutical Research 4(4): 293-300, 1987

Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran size. Anti-Cancer Drugs 11(5): 377-384, 2000

Synthesis of dextran derivatives with thiol-specific reactive groups for the preparation of dextran-protein conjugates. Bioconjugate Chemistry 4(5): 402-405, 1993

Physicochemical studies on dextran. VI. The sedimentation and diffusion behavior of dextran after ultrasonic treatment. Die Pharmazie 14: 380-392, 1959

Preparative and Analytical Separation of Insulin-Dextran Conjugates From Native Insulin: Application to Preparation and Characterization of Insulin-Dextran Conjugates. Drug Development and Industrial Pharmacy 20(3): 395-404, 1994

Physicochemical study of dextran. III. Complete decomposition of dextran with acids, ultraviolet rays and ultrasounds. Die Pharmazie 11(7): 462-470, 1956